DOI:
10.1055/s-00000071
Seminars in Neurology
LinksClose Window
References
van Dyck CH, Tariot PN, Meyers B, Malca Resnick E. ; Memantine MEM-MD-01 Study Group.
A 24-week randomized, controlled trial of memantine in patients with moderate-to-severe Alzheimer disease.
Alzheimer Dis Assoc Disord 2007;
21 (02) 136-143
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.